As our data demonstrates that abrogation of Treg CD27 in combination with PD-1 signaling blockade affects CD8+ T cells numbers within the tumor, we next assessed effector function of intratumoral CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.